Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
BMS’ pivotal CAR-T multiple myeloma trial hits primary endpoint
The GPRC5D-directed CAR-T cell therapy trial hit its goal, furthering the BMS' efforts to challenge J&J for the post-BCMA multiple myeloma market.
Nick Paul Taylor
Sep 8, 2026 9:11am
Novartis halts autoimmune CAR-T trials after 3 deaths
Aug 31, 2026 6:25pm
Chai tees up BMS AI antibody discovery collab
Aug 20, 2026 10:55am
Fierce Pharma
Editor’s Corner: Why an AZ-BMS merger would be a very bad idea
Aug 3, 2026 12:25am
BMS CEO doesn’t ‘feel any compulsion to chase deals’
Jul 30, 2026 10:37am
Fierce Pharma
BMS delays key Cobenfy, milvexian readouts amid Q2 beat
Jul 30, 2026 10:12am
